CLPTM1L and ovarian cancer: One study has linked CLPTM1L expression with cisplatin resistance in an ovarian cancer cell line (Yamamoto et al. 2001) and more recently, CLPTM1L was shown to promote growth and enhance chromosomal instability in pancreatic cancer cell lines (Jia et al. 2014).